Abbott Laboratories files a Form 4 with the U.S. Securities and Exchange Commission for July 1, according to Investing.com. Form 4 filings are typically used to report transactions in a company’s securities by certain insiders, such as directors, officers, or beneficial owners. The provided source does not include additional details such as the filer’s identity, the number of shares involved, whether the transaction is a purchase or sale, the transaction price, or whether the filing relates to exercise of options or other changes in beneficial ownership. As a result, the publicly available information in the supplied material is limited to the fact that the company has submitted the Form 4 on the specified date. Further particulars would normally be available in the SEC filing itself, including the transaction type and the amount of securities. No other outlets or additional article text were provided for cross-checking in this prompt.